3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine

C135H167N33O18 — CID 157221648

IUPAC3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine
SMILESCc1cccc(C/N=C/c2nc(OCCN3CCOC3=O)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOC3=O)nc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOCC3)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOCC3)nc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCc3ccccn3)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCc3ccccn3)nc(N3CCOCC3)n2)c1
InChIInChI=1S/C24H27N5O2.C23H26N6O2.C23H31N5O3.C22H30N6O3.C22H27N5O4.C21H26N6O4/c1-19-5-4-6-20(15-19)17-25-18-22-27-23(29-10-13-30-14-11-29)16-24(28-22)31-12-8-21-7-2-3-9-26-21;1-18-5-4-6-19(15-18)16-24-17-21-26-22(29-10-13-30-14-11-29)28-23(27-21)31-12-8-20-7-2-3-9-25-20;1-19-3-2-4-20(15-19)17-24-18-21-25-22(28-8-12-30-13-9-28)16-23(26-21)31-14-7-27-5-10-29-11-6-27;1-18-3-2-4-19(15-18)16-23-17-20-24-21(28-8-12-30-13-9-28)26-22(25-20)31-14-7-27-5-10-29-11-6-27;1-17-3-2-4-18(13-17)15-23-16-19-24-20(26-5-9-29-10-6-26)14-21(25-19)30-11-7-27-8-12-31-22(27)28;1-16-3-2-4-17(13-16)14-22-15-18-23-19(26-5-9-29-10-6-26)25-20(24-18)30-11-7-27-8-12-31-21(27)28/h2-7,9,15-16,18H,8,10-14,17H2,1H3;2-7,9,15,17H,8,10-14,16H2,1H3;2-4,15-16,18H,5-14,17H2,1H3;2-4,15,17H,5-14,16H2,1H3;2-4,13-14,16H,5-12,15H2,1H3;2-4,13,15H,5-12,14H2,1H3/b25-18+;24-17+;24-18+;23-17+;23-16+;22-15+
InChIKeyATBKDQBDYGKUDT-RJZVVZEKSA-N
MW2540.03 g/mol
LogP12.75
Rot. Bonds48

About 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine

3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine (PubChem CID 157221648) has the molecular formula C135H167N33O18 and a molecular weight of 2540.03 g/mol. Its IUPAC name is 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine.

Molecular Properties

Compound Name3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine
PubChem CID157221648
Molecular FormulaC135H167N33O18
Molecular Weight2540.03 g/mol
Exact Mass2538.32
IUPAC Name3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine
SMILESCc1cccc(C/N=C/c2nc(OCCN3CCOC3=O)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOC3=O)nc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOCC3)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOCC3)nc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCc3ccccn3)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCc3ccccn3)nc(N3CCOCC3)n2)c1
InChIInChI=1S/C24H27N5O2.C23H26N6O2.C23H31N5O3.C22H30N6O3.C22H27N5O4.C21H26N6O4/c1-19-5-4-6-20(15-19)17-25-18-22-27-23(29-10-13-30-14-11-29)16-24(28-22)31-12-8-21-7-2-3-9-26-21;1-18-5-4-6-19(15-18)16-24-17-21-26-22(29-10-13-30-14-11-29)28-23(27-21)31-12-8-20-7-2-3-9-25-20;1-19-3-2-4-20(15-19)17-24-18-21-25-22(28-8-12-30-13-9-28)16-23(26-21)31-14-7-27-5-10-29-11-6-27;1-18-3-2-4-19(15-18)16-23-17-20-24-21(28-8-12-30-13-9-28)26-22(25-20)31-14-7-27-5-10-29-11-6-27;1-17-3-2-4-18(13-17)15-23-16-19-24-20(26-5-9-29-10-6-26)14-21(25-19)30-11-7-27-8-12-31-22(27)28;1-16-3-2-4-17(13-16)14-22-15-18-23-19(26-5-9-29-10-6-26)25-20(24-18)30-11-7-27-8-12-31-21(27)28/h2-7,9,15-16,18H,8,10-14,17H2,1H3;2-7,9,15,17H,8,10-14,16H2,1H3;2-4,15-16,18H,5-14,17H2,1H3;2-4,15,17H,5-14,16H2,1H3;2-4,13-14,16H,5-12,15H2,1H3;2-4,13,15H,5-12,14H2,1H3/b25-18+;24-17+;24-18+;23-17+;23-16+;22-15+
InChIKeyATBKDQBDYGKUDT-RJZVVZEKSA-N
XLogP12.75
TPSA507.51 Ų
H-Bond Donors
H-Bond Acceptors49
Rotatable Bonds48
Heavy Atoms186
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002540.03
LogP ≤ 512.75
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1049

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine?
The IUPAC name of 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine (CID 157221648) is 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine.
What is the SMILES notation for 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine?
The canonical SMILES for 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine is Cc1cccc(C/N=C/c2nc(OCCN3CCOC3=O)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOC3=O)nc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOCC3)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCN3CCOCC3)nc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCc3ccccn3)cc(N3CCOCC3)n2)c1.Cc1cccc(C/N=C/c2nc(OCCc3ccccn3)nc(N3CCOCC3)n2)c1.
What is the InChIKey of 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine?
The InChIKey is ATBKDQBDYGKUDT-RJZVVZEKSA-N. The full InChI is InChI=1S/C24H27N5O2.C23H26N6O2.C23H31N5O3.C22H30N6O3.C22H27N5O4.C21H26N6O4/c1-19-5-4-6-20(15-19)17-25-18-22-27-23(29-10-13-30-14-11-29)16-24(28-22)31-12-8-21-7-2-3-9-26-21;1-18-5-4-6-19(15-18)16-24-17-21-26-22(29-10-13-30-14-11-29)28-23(27-21)31-12-8-20-7-2-3-9-25-20;1-19-3-2-4-20(15-19)17-24-18-21-25-22(28-8-12-30-13-9-28)16-23(26-21)31-14-7-27-5-10-29-11-6-27;1-18-3-2-4-19(15-18)16-23-17-20-24-21(28-8-12-30-13-9-28)26-22(25-20)31-14-7-27-5-10-29-11-6-27;1-17-3-2-4-18(13-17)15-23-16-19-24-20(26-5-9-29-10-6-26)14-21(25-19)30-11-7-27-8-12-31-22(27)28;1-16-3-2-4-17(13-16)14-22-15-18-23-19(26-5-9-29-10-6-26)25-20(24-18)30-11-7-27-8-12-31-21(27)28/h2-7,9,15-16,18H,8,10-14,17H2,1H3;2-7,9,15,17H,8,10-14,16H2,1H3;2-4,15-16,18H,5-14,17H2,1H3;2-4,15,17H,5-14,16H2,1H3;2-4,13-14,16H,5-12,15H2,1H3;2-4,13,15H,5-12,14H2,1H3/b25-18+;24-17+;24-18+;23-17+;23-16+;22-15+.
What are the key properties of 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine?
3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine has a molecular weight of 2540.03 g/mol, XLogP of 12.75, 48 rotatable bonds, 0 hydrogen bond donors, and 49 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[2-[2-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-ylpyrimidin-4-yl]oxyethyl]-1,3-oxazolidin-2-one;3-[2-[[4-[(3-methylphenyl)methyliminomethyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]ethyl]-1,3-oxazolidin-2-one;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)pyrimidin-2-yl]methanimine;N-[(3-methylphenyl)methyl]-1-[4-morpholin-4-yl-6-(2-pyridin-2-ylethoxy)-1,3,5-triazin-2-yl]methanimine is sourced from PubChem (CID 157221648), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).